1. Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia. (29th August 2020) Authors: Gaudet, Daniel; Karwatowska-Prokopczuk, Ewa; Baum, Seth J; Hurh, Eunju; Kingsbury, Joyce; Bartlett, Victoria J; Figueroa, Amparo L; Piscitelli, Philip; Singleton, Walter; Witztum, Joseph L; Geary, Richard S; Tsimikas, Sotirios; O'Dea, Louis St. L Journal: European heart journal Issue: Volume 41:Number 40(2020) Page Start: 3936 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗